INNT
TOTAL INVALIDATION PROCESSED BY THE IB
10/08/2024
Voltar para busca
Dado oficial do USPTO
COBRAHOOD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
10/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10
Data de depósito
11/02/2016
Data de registro
04/04/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/10/2023
Última transação
23/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
ORTIGA PALMER, RAMONA
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Vascutek Limited
Representantes
Thomas W. Cole RobertsMlotkowskiSafranCole&Calderon PC
Classificação técnica
Classes Nice
Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Surgical apparatus and instruments for treating cardiovascular disease; medical apparatus and instruments for treating cardiovascular disease; artificial prosthetic vascular grafts; knitted polyester vascular grafts; stents; prostheses; vascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; woven synthetic stent grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and/or reconstruction of internal tissue namelycardiovascular patches in the nature of artificial vascular graftspericardial patches in the nature of artificial vascular graftscarotid patchessurgical mesh comprised primarily of prosthetic materials; implantable medical systemscardiac valves for surgical prosthesesstentsprosthetic vascular graftsvascular prosthesesprosthetic endovascular grafts and catheters; implantable medical devicesimplants consisting of prosthetic materialssynthetic vascular prosthesesprosthetic vascular grafts and synthetic heart valve conduits; vascular grafts; endovascular grafts; medical systems comprised of stents and synthetic stent grafts and medical devices all for use in endovascular procedures; thoracic stents; thoracic stent grafts; stent grafts; synthetic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; stent graft systems and devices comprising components of more than one stent graftcomprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; synthetic stent graft systems and devices comprising components of more than one type of stent graft synthetic stent graftsstent delivery systemsstent graft delivery systems; synthetic thoracic stent graft systems comprised of synthetic stent graftsstent delivery systemsstent graft delivery systems; artificial thoracic stent graft devices namelyartificial thoracic stent grafts; synthetic grafts for systemic vascular repair; artificial grafts for bypass or reconstruction of peripheral arterial blood vessels; artificial straight synthetic grafts; artificial abdominal grafts; artificial thoracic grafts; artificial branched vascular grafts; artificial pre-curved vascular grafts; artificial aortic arch grafts; artificial branched arch vascular grafts; delivery systems for synthetic stent graft systems and stent graft devices comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent graftsstent or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systemsprosthetic cardiac valves; artificial heart valves; artificial heart valve conduits; parts and fittings for all of the aforementioned goods
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21/07/2024
INPC
INVALIDATION PROCESSED
20/07/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
21/06/2024
C71T
CANCELLED SECTION 71
20/10/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/04/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/07/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/07/2017
FIMP
FINAL DISPOSITION PROCESSED
05/07/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
GPNX
NOTIFICATION PROCESSED BY IB
26/01/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/01/2017
PUBO
PUBLISHED FOR OPPOSITION
17/01/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/01/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/01/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/08/2016
GNRT
NON-FINAL ACTION E-MAILED
18/08/2016
CNRT
NON-FINAL ACTION WRITTEN
18/08/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/07/2016
RFNP
REFUSAL PROCESSED BY IB
02/07/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/06/2016
RFRR
REFUSAL PROCESSED BY MPU
16/06/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/06/2016
CNRT
NON-FINAL ACTION WRITTEN
15/06/2016
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
15/06/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/06/2016
CNRT
NON-FINAL ACTION WRITTEN
14/06/2016
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
06/06/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/06/2016
CNRT
NON-FINAL ACTION WRITTEN
03/06/2016
MAFR
APPLICATION FILING RECEIPT MAILED
31/05/2016
DOCK
ASSIGNED TO EXAMINER
27/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/05/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COBRAHOOD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.